Correlation Between Novo Nordisk and ChemoMetec
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ChemoMetec at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ChemoMetec into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and ChemoMetec AS, you can compare the effects of market volatilities on Novo Nordisk and ChemoMetec and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ChemoMetec. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ChemoMetec.
Diversification Opportunities for Novo Nordisk and ChemoMetec
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Novo and ChemoMetec is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ChemoMetec AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChemoMetec AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ChemoMetec. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChemoMetec AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ChemoMetec go up and down completely randomly.
Pair Corralation between Novo Nordisk and ChemoMetec
Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the ChemoMetec. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 2.83 times less risky than ChemoMetec. The stock trades about 0.0 of its potential returns per unit of risk. The ChemoMetec AS is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 40,000 in ChemoMetec AS on September 1, 2024 and sell it today you would earn a total of 7,360 from holding ChemoMetec AS or generate 18.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. ChemoMetec AS
Performance |
| Timeline |
| Novo Nordisk AS |
| ChemoMetec AS |
Novo Nordisk and ChemoMetec Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and ChemoMetec
The main advantage of trading using opposite Novo Nordisk and ChemoMetec positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ChemoMetec can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoMetec will offset losses from the drop in ChemoMetec's long position.| Novo Nordisk vs. Vestas Wind Systems | Novo Nordisk vs. Danske Bank AS | Novo Nordisk vs. Bavarian Nordic | Novo Nordisk vs. DSV Panalpina AS |
| ChemoMetec vs. cBrain AS | ChemoMetec vs. Ambu AS | ChemoMetec vs. Genmab AS | ChemoMetec vs. Zealand Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |